Standout Papers

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomi... 1996 2026 2006 2016 1.8k
  1. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial (2002)
    Jean‐Louis Chiasson, Robert G. Josse et al. The Lancet
  2. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial (2006)
    Hertzel C. Gerstein, Salim Yusuf et al. The Lancet
  3. Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance (2003)
    Jean‐Louis Chiasson, Robert G. Josse et al. JAMA
  4. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial (2009)
    Philip Home, Stuart Pocock et al. The Lancet
  5. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up (1996)
    M Hanefeld, Sven Fischer et al. Diabetologia
  6. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis (2007)
    Philip Home, Stuart Pocock et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 138 standout
Sub-graph 1 of 16

Citing Papers

Diagnosis and Management of Prediabetes
2023 Standout
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
2021 Standout
40 intermediate papers

Works of M Hanefeld being referenced

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
2011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
and 20 more

Author Peers

Author Last Decade Papers Cites
M Hanefeld 12442 6023 2690 3208 303 18.0k
Katherine R. Tuttle 7969 3519 3204 3409 291 18.4k
Michel Marre 8347 3848 3658 3239 419 16.6k
Giorgio Sesti 6697 5502 2636 3352 406 14.6k
André Scheen 10314 5185 1802 4432 749 19.2k
Ramón Gomis 8339 3760 3864 3050 172 14.4k
Itamar Raz 14772 6002 6237 5439 370 25.1k
Sho‐ichi Yamagishi 7631 5895 2687 2154 444 22.7k
Masakazu Haneda 5304 4741 2384 2668 290 15.8k
Απόστολος Τσάπας 16339 6661 1237 5166 156 20.3k
Eiichi Araki 7382 9268 1730 5642 298 21.0k

All Works

Loading papers...

Rankless by CCL
2026